Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Identification of Spermine as an Inhibitor of Erythropoiesis in Patients with Chronic Renal Failure
Heinz W. Radtke, … , Robert A. Campbell, James W. Fisher
Heinz W. Radtke, … , Robert A. Campbell, James W. Fisher
Published June 1, 1981
Citation Information: J Clin Invest. 1981;67(6):1623-1629. https://doi.org/10.1172/JCI110197.
View: Text | PDF
Research Article

Identification of Spermine as an Inhibitor of Erythropoiesis in Patients with Chronic Renal Failure

  • Text
  • PDF
Abstract

Fetal mouse liver and normal human bone marrow cell cultures were used for studies on the inhibition of erythroid colony formation (CFU-E) by sera from anemic patients with end-stage renal failure and the polyamine spermine. Sera from each of eight predialysis uremic anemic patients with end-stage renal failure produced a significant (P < 0.001) inhibition of erythroid colony formation in the fetal mouse liver cell cultures when compared to sera from normal human volunteers. In vivo or in vitro dialysis of the uremic sera with a 3,500-dalton exclusion limit membrane removed the inhibitor from uremic sera. The uremic serum dialysate provided by the membrane fractionation was significantly inhibitory in the erythroid cell cultures. When this dialysate was applied to gel filtration chromatography (Bio-Gel P-2) the inhibitor was found to be in the same molecular weight range as [14C]spermine. The polyamine spermine produced a dose-related inhibition of erythroid colony formation (CFU-E) in fetal mouse liver and normal human bone marrow cultures. Thus, the following evidence is provided that the in vitro inhibitor of erythropoiesis found in chronic renal failure patients' sera is identical with the polyamine spermine: (a) the inhibitor and radiolabeled spermine appeared in identical Bio-Gel P-2 effluent fractions; (b) when spermine was added to normal human sera at concentrations reported in sera of uremic patients, and studied in both the fetal mouse liver cell culture and normal human bone marrow cultures, a dose-related inhibition of erythroid colony (CFU-E) formation was noted; and (c) the inhibitory effects of crude uremic serum, uremic serum dialysate, and fractions of uremic serum dialysate from a Bio-Gel column, on erythroid colony formation were completely abolished by the addition of a specific rabbit antiserum to spermine.

Authors

Heinz W. Radtke, Arvind B. Rege, Max B. Lamarche, Dagmar Bartos, Frantisek Bartos, Robert A. Campbell, James W. Fisher

×

Total citations by year

Year: 2022 2021 2020 2018 2017 2016 2015 2014 2013 2012 2011 2010 2008 2006 2005 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982 1981 1980 1979 Total
Citations: 1 1 1 4 1 1 1 2 5 1 3 3 1 2 1 2 3 2 3 3 1 2 1 1 3 2 3 1 3 7 2 7 5 4 6 4 3 1 1 1 99
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (99)

Title and authors Publication Year
Indoxyl sulfate impairs in vitro erythropoiesis by triggering apoptosis and senescence
Duangchan T, Rattanasompattikul M, Chitchongyingcharoen N, Mas-Oodi S, Promkan M, Rongkiettechakorn N, Korpraphong S, Supokawej A
Experimental Biology and Medicine 2022
Hematological, immunological, and polyamines alterations in the concomitant occurrence of Fasciola gigantica and hepatic leiomyoma in cattle
S Shahvazi, S Esmaeilzadeh, S Bahrami, H Najafzadeh
Veterinary Parasitology 2021
Uremic Toxins Affect Erythropoiesis during the Course of Chronic Kidney Disease: A Review
E Hamza, L Metzinger, VM Meuth
Cells 2020
Physiology and pathophysiology of renal erythropoietin-producing cells
HM Shih, CJ Wu, SL Lin
Journal of the Formosan Medical Association = Taiwan yi zhi 2018
Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
R Vanholder, A Pletinck, E Schepers, G Glorieux
Toxins 2018
Generation, clearance, toxicity and monitoring possibilities of unaccounted uremic toxins for improved dialysis prescriptions
JG Atherton, DS Hains, JJ Bissler, BD Pendley, E Lindner
American journal of physiology. Renal physiology 2018
Anemia in the Young and Old: Diagnosis and Management
RT Means
2018
Hemodialysis Membranes: For Engineers to Medical Practitioners
S De, A Roy
2017
Role of anuria in the relationship between indoxyl sulfate and anemia in peritoneal dialysis patients
JY Huang, CW Hsu, CW Yang, CC Hung, WH Huang
Therapeutics and Clinical Risk Management 2016
Urinary metabolomics and biomarkers of aristolochic acid nephrotoxicity by UPLC-QTOF/HDMS
YY Zhao, DD Tang, H Chen, JR Mao, X Bai, XH Cheng, XY Xiao
Bioanalysis 2015
Comprehensive Physiology
SN Cheuvront, RW Kenefick
Comprehensive Physiology 2014
Calcium Sensing Receptor Modulates Extracellular Calcium Entry and Proliferation via TRPC3/6 Channels in Cultured Human Mesangial Cells
K Meng, J Xu, C Zhang, R Zhang, H Yang, C Liao, J Jiao, MP Rastaldi
PloS one 2014
Nutritional Management of Renal Disease
A Molfino, BR Don, GA Kaysen
Nutritional Management of Renal Disease 2013
Seldin and Giebisch's The Kidney
CJ Cooper, LD Dworkin, WL Henrich
Seldin and Giebisch's The Kidney 2013
Cationic uremic toxins affect human renal proximal tubule cell functioning through interaction with the organic cation transporter
CM Schophuizen, MJ Wilmer, J Jansen, L Gustavsson, C Hilgendorf, JG Hoenderop, LP Heuvel, R Masereeuw
Pflügers Archiv - European Journal of Physiology 2013
Clinical Pharmacokinetics and Pharmacodynamics of Erythropoiesis-Stimulating Agents
S Doshi, W Krzyzanski, S Yue, S Elliott, A Chow, JJ Pérez-Ruixo
Clinical Pharmacokinetics 2013
Cationic uremic toxins affect human renal proximal tubule cell functioning through interaction with the organic cation transporter
CM Schophuizen, MJ Wilmer, J Jansen, L Gustavsson, C Hilgendorf, JG Hoenderop, LP van den Heuvel, R Masereeuw
Pflügers Archiv - European Journal of Physiology 2013
Brenner and Rector's The Kidney
C Brugnara, KU Eckardt
Brenner and Rector's The Kidney 2012
Advances in Clinical Chemistry
M Mahler
Advances in Clinical Chemistry Volume 54 2011
Practical Urology: Essential Principles and Practice
CR Chapple, WD Steers
2011
Anemia of Renal Disease: What it is, what to do and what's new
Chalhoub S, Langston C, Eatroff A
Journal of Feline Medicine and Surgery 2011
Inhibition of apoptotic signalling in spermine-treated vascular smooth muscle cells by a novel glutathione precursor
I Sinha‑Hikim, R Shen, E Kovacheva, A Crum, ND Vaziri, KC Norris
Cell Biology International 2010
Landmark advances in the development of erythropoietin
JW Fisher
Experimental biology and medicine (Maywood, N.J.) 2010
Effects of a novel cystine-based glutathione precursor on oxidative stress in vascular smooth muscle cells
I Sinha-Hikim, R Shen, WN Lee, A Crum, ND Vaziri, KC Norris
American journal of physiology. Cell physiology 2010
Nocturnal Hemodialysis Improves Erythropoietin Responsiveness and Growth of Hematopoietic Stem Cells
CT Chan, PP Liu, S Arab, N Jamal, HA Messner
Journal of the American Society of Nephrology : JASN 2008
Polyamines as an Inhibitor on Erythropoiesis of Hemodialysis Patients by In Vitro Bioassay Using the Fetal Mouse Liver Assay
K Yoshida, T Yoneda, S Kimura, K Fujimoto, E Okajima, Y Hirao
Therapeutic Apheresis and Dialysis 2006
Controversies in renal anemia management
O Ifudu
Dialysis & Transplantation 2006
Reviews: Uremic Toxins: A New Focus on an Old Subject
A Yavuz, C Tetta, FF Ersoy, V D’intini, R Ratanarat, MD Cal, M Bonello, V Bordoni, G Salvatori, E Andrikos, G Yakupoglu, NW Levin, C Ronco
Seminars in Dialysis 2005
Low water-soluble uremic toxins
RC Vanholder, G Glorieux, RD Smet, PP de Deyn
Advances in renal replacement therapy 2003
Erythropoietin: Physiology and Pharmacology Update
JW Fisher
Experimental biology and medicine (Maywood, N.J.) 2003
Reduced Requirement for Erythropoietin with Quotidian Hemodialysis Therapy
S Klarenbach, AP Heidenheim, R Leitch, RM Lindsay
ASAIO Journal 2002
Renal Anemia
O Ifudu
2002
Trends in Anemia Management among US Hemodialysis Patients
JA Coladonato, DL Frankenfield, DN Reddan, PS Klassen, LA Szczech, CA Johnson, WF Owen
Journal of the American Society of Nephrology : JASN 2002
Role of uremic toxins in exacerbating anemia in renal failure
IC Macdougall
Kidney International 2001
Adequacy of dialysis reduces the doses of recombinant erythropoietin independently from the use of biocompatible membranes in haemodialysis patients
E Movilli, GC Cancarini, R Zani, C Camerini, M Sandrini, R Maiorca
Nephrology Dialysis Transplantation 2001
Gene Electrotransfer Results in a High-Level Transduction of Rat Skeletal Muscle and Corrects Anemia of Renal Failure
G Rizzuto, M Cappelletti, C Mennuni, MI Wiznerowicz, A Demartis, D Maione, G Ciliberto, NL Monica, E Fattori
Human Gene Therapy 2000
Adequacy of dialysis and differences in hematocrit among dialysis facilities
O Ifudu, J Uribarri, I Rajwani, V Vlacich, K Reydel, G Delosreyes, EA Friedman
American Journal of Kidney Diseases 2000
Anaemia correction—does the mode of dialysis matter?
KU Eckardt
Nephrology Dialysis Transplantation 2000
The Anemia in Continuous Ambulatory Peritoneal Dialysis Patients Is Related to Kt/V Index
K Opatrny, S Opatrna, F Sefrna, J Wirth
Artificial Organs 1999
Functional Iron Deficiency and Inadequate Dialysis: Is There a Connection?
O Ifudu
The International Journal of Artificial Organs 1999
Insulin-Like Growth Factor I Plays a Role in Regulating Erythropoiesis in Patients with End-Stage Renal Disease and Erythrocytosis
LY Shih, JY Huang, CT Lee
Journal of the American Society of Nephrology : JASN 1999
A QUEST FOR ERYTHROPOIETIN OVER NINE DECADES
JW Fisher
Annual Review of Pharmacology and Toxicology 1998
Influence of bisphosphonate on the negative erythropoietic effects of uranyl nitrate
MJ Giglio, A Frid, CE Bozzini
International Journal of Clinical & Laboratory Research 1997
Erythropoietin in the pathogenesis and treatment of the anemia of chronic renal failure
AJ Erslev, A Besarab
Kidney International 1997
The Intensity of Hemodialysis and the Response to Erythropoietin in Patients with End-Stage Renal Disease
O Ifudu, J Feldman, EA Friedman
New England Journal of Medicine 1996
l-Carnitine effects on anemia in hemodialyzed patients treated with erythropoietin
WD Labonia
American Journal of Kidney Diseases 1995
Middle Molecules as Uremic Toxins: Still a Viable Hypothesis?
R Vanholder
Seminars in Dialysis 1994
Transforming growth factor beta 1 is an inducer of erythroid differentiation
G Krystal, V Lam, W Dragowska, C Takahashi, J Appel, A Gontier, A Jenkins, H Lam, L Quon, P Lansdorp
Journal of Experimental Medicine 1994
Advances in Pharmacology
B Drenger, Y Ginosar, Y Gozal
Advances in Pharmacology 1994
Burst&hyphen;promoting activity in the serum of patients with chronic renal failure undergoing long&hyphen;term hemodialysis
G Randall, J Meyer, C Swanepoel, P Jacobs
Stem Cells 1993
Epoetin: A Pharmacoeconomic Review of its Use in Chronic Renal Failure and its Effects on Quality of Life
R Whittington, LB Barradell, P Benfield
PharmacoEconomics 1993
A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects
JW Eschbach, NR Haley, JC Egrie, JW Adamson
Kidney International 1992
The existence of activin A / erythroid differentiation factor and its inhibitor in human serum: Comparison of normal and chronic renal failure sera
M Shiozaki, R Sakai, M Tabuchi, M Shinohara, M Kosaka, S Saito, Y Eto
Biochemical and Biophysical Research Communications 1992
Biochemical Pharmacology of Blood and Bloodforming Organs
JW Fisher
1992
Polyamines in the anemia of end-stage renal disease
D Kushner, B Beckman, L Nguyen, S Chen, CD Santina, F Husserl, J Rice, JW Fisher
Kidney International 1991
Pharmacokinetics of intravenous recombinant human erythropoietin in patients with chronic renal failure
T Salmonson, BG Danielson, A Grahnén, B Wikström
Journal of Internal Medicine 1990
Effects of Theophylline on Erythropoietin Production in Normal Subjects and in Patients with Erythrocytosis after Renal Transplantation
GL Bakris, ER Sauter, JL Hussey, JW Fisher, AO Gaber, R Winsett
New England Journal of Medicine 1990
Growth Factors, Differentiation Factors, and Cytokines
A Habenicht
1990
The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin
JW Eschbach
Kidney International 1989
Recent Developments in the Anemia of Chronic Renal Failure
A Besarab, JF Girone, A Erslev, J Caro
Seminars in Dialysis 1989
Prostaglandin-mediated suppression of in vitro growth of erythroid progenitor cells
S Taniguchi, T Shibuya, M Harada, Y Niho
Kidney International 1989
Hematologic aspects of renal insufficiency
GJ Schiller, SA Berkman
Blood Reviews 1989
Treatment of fetal bovine serum with activated charcoal enhances spontaneous differentiation of murine erythroleukemia cells
T Murate, T Kaneda
Leukemia Research 1989
Serum Erythropoietin Levels after Renal Transplantation
CH Sun, H Ward, WL Paul, MA Koyle, N Yanagawa, DB Lee
New England Journal of Medicine 1989
New Perspectives in Hemodialysis, Peritoneal Dialysis, Arteriovenous Hemofiltration, and Plasmapheresis
WH Hörl, PJ Schollmeyer
1989
The anemia of end-stage renal disease: Hematopoietic progenitor cell response
GM Segal, JW Eschbach, JC Egrie, T Stueve, JW Adamson
Kidney International 1988
Recombinant Human Erythropoietin: Implications for Nephrology
JW Eschbach, JW Adamson
American Journal of Kidney Diseases 1988
Erythropoietin–hematocrit feedback circuit in the anemia of end–stage renal disease
AJ Walle, GY Wong, GK Clemons, JF Garcia, W Niedermayer
Kidney International 1987
Spermine and spermidine are non-specific inhibitors of in vitro hematopoiesis
GM Segal, T Stueve, JW Adamson
Kidney International 1987
Correction of the Anemia of End-Stage Renal Disease with Recombinant Human Erythropoietin
JW Eschbach, JC Egrie, MR Downing, JK Browne, JW Adamson
New England Journal of Medicine 1987
Polycythemia in Chronic Obstructive Pulmonary Disease
B Guidet, G Offenstadt, G Boffa, A Najman, C Baillou, C Hatzfeld, P Amstutz
Chest 1987
Hematologic Abnormalities in Patients with Renal Diseases
WG Hocking
Hematology/Oncology Clinics of North America 1987
Uremic Toxins
S Ringoir, R Vanholder, SG Massry
1987
Chronic Ambulatory Peritoneal Dialysis (CAPD) and Chronic Cycling Peritoneal Dialysis (CCPD) in Children
RN Fine
1987
Is lower ploidy of megakaryocytes another reason for uremic thrombocytopathy?
M Winkelmann, U Dorr, P Pfitzer, W Schneider
Klinische Wochenschrift 1986
Hematopoietic inhibitors in chronic renal failure: Lack of in vitro specificity
F Delwiche, GM Segal, JW Eschbach, JW Adamson
Kidney International 1986
Potential Role of Serum Inhibitors of Erythropoiesis in the Anemia Associated With Infection, Renal Disease and Malignancy in the Dog
DJ Weiss
Veterinary Clinical Pathology 1986
The anaemia of chronic renal failure: A potentially treatable catabolic phenomenon?
JS Shannon, TR Lappin
Medical Hypotheses 1986
Toxins and Inhibitors in Chronic Renal Failure
D Powell, J Bergstrom, R Dzurik, P Gulyassy, D Lockwood, L Phillips
American Journal of Kidney Diseases 1986
Anemia of end-stage renal disease (ESRD)
JW Eschbach, JW Adamson
Kidney International 1985
Polyamines in clinical disorders
DF Tierney, LJ Marton, AD Hacker, N Lowe
The Western journal of medicine 1985
Effect of amines on erythropoietin-stimulated heme synthesis in fetal mouse liver cells
JT Dulaney, FE Hatch, J Young
Life Sciences 1985
Aluminum-Induced Anemia
L Kaiser, KA Schwartz
American Journal of Kidney Diseases 1985
The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo
JW Eschbach, J Mladenovic, JF Garcia, PW Wahl, JW Adamson
Journal of Clinical Investigation 1984
Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency
RJ McGonigle, JD Wallin, RK Shadduck, JW Fisher
Kidney International 1984
The anaemia of chronic renal failure in sheep: studies in vitro
J Mladenovic, JW Eschbach, JF Garcia, JW Adamson
British Journal of Haematology 1984
Hemodialysis and continuous ambulatory peritoneal dialysis effects on erythropoiesis in renal failure
RJ McGonigle, F Husserl, JD Wallin, JW Fisher
Kidney International 1984
Inhibition of Erythropoiesis in Chronic Renal Failure: The Role of Parathyroid Hormone
JD Lutton, KB Solangi, NG Ibraham, AI Goodman, RD Levere
American Journal of Kidney Diseases 1984
Therapy of Renal Diseases and Related Disorders
WN Suki, SG Massry
1984
Deficient feedback regulation of erythropoiesis in kidney transplant patients with polycythemia
F Thevenod, HW Radtke, P Grützmacher, E Vincent, KM Koch, W Schoeppe, W Fassbinder
Kidney International 1983
Influence of continuous ambulatory peritoneal dialysis on the anemia of endstage renal disease
MB de Paepe, KH Schelstraete, SM Ringoir, NH Lameire
Kidney International 1983
Determination of polyamines in hydrolysates of uremic plasma by high-performance cation-exchange column chromatography
T Takagi, TG Chung, A Saito
Journal of Chromatography B: Biomedical Sciences and Applications 1983
Ribonuclease Inhibition of Erythropoiesis in Anemia of Uremia
MH Freedman, EF Saunders, DC Cattran, EZ Rabin
American Journal of Kidney Diseases 1983
Erythropoietin-independent erythroid colony formation in patients with erythroleukaemia (M6) and related disorders
WF Anderson, B Beckman, G Beltran, JW Fisher, WJ Stuckey
British Journal of Haematology 1982
Mixed myeloid—lymphoid colonies in a patient with polycythemia vera
B Beckman, WF Anderson, G Beltran, I Chen, JW Fisher
American Journal of Hematology 1982
Normalization of hematocrit in patients with end-stage renal disease on continuous ambulatory peritoneal dialysis
AR Zappacosta, J Caro, A Erslev
The American Journal of Medicine 1982
Contemporary Nephrology
S Klahr, SG Massry
1981
Verhandlungen der Deutschen Gesellschaft für innere Medizin
B Schlegel
1980
Replacement of Renal Function by Dialysis
W Drukker, FM Parsons, JF Maher
1979

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts